An FDA independent advisory panel recommended that a blood test to detect colon cancer be approved. Here's what you need to know.
The Shield blood test was able to accurately detect colorectal cancer about 83 percent of the time. It was able to detect precancerous lesions about 13 percent of the time. The prescription-only ...
May 23 (UPI) --A panel of U.S. Food and Drug Administration advisers on Thursday recommended approval for a new blood test to detect colon and rectal cancer despite concerns over the test's accuracy.
To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but ...
Opinion: Medicare must provide immediate coverage for new preventive care tools and services for treating cancer.
Multi-cancer early detection tests (MCEDs), sometimes called liquid biopsy tests, are a new method of detecting cancer early.
On May 16, 2024, the FDA granted a breakthrough therapy designation to NVL-655, a novel brain-penetrant ALK-selective ...
To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but also ...